Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Roche, Trimeris pull Fuzeon sNDA

Roche (SWX:ROG) and TRMS withdrew an sNDA for the inclusion of the Biojector 2000 (B2000) needle-free injection device

Read the full 182 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE